Europe Syndromic Multiplex Diagnostic Market to 2032

Overview

The Europe Syndromic Multiplex Diagnostic Market is expected to reach a 2.20 USD Billion by 2032 and is projected to grow at a CAGR of 8.22% from 2025 to 2032.

Revenue, 2024 (USD Billion)

1.17

Forecast, 2032 (USD Billion)

2.20

CAGR, 2024 - 2032

8.22%

Report Coverage

Europe

Europe Syndromic Multiplex Diagnostic Market 2018-2032 USD Billion

Europe Syndromic Multiplex Diagnostic Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 1.17 USD Billion
Projected Market Size (2032): 2.20 USD Billion
CAGR (2025-2032): 8.22%

Key Findings of Europe Syndromic Multiplex Diagnostic Market

The Europe Syndromic Multiplex Diagnostic Market was valued at 1.17 USD Billion in 2024.
The Europe Syndromic Multiplex Diagnostic Market is likely to grow at a CAGR of 8.22% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 0.82 USD Billion
The fastest growing segment Respiratory Infections in Disease Segment grew Fastest with a CAGR of 9.40% during the forecast period from 2024 to 2032.

Europe Syndromic Multiplex Diagnostic Market Scope

Europe Syndromic Multiplex Diagnostic Market Segmentation & Scope

Product Type

Software & Services
Instruments
Accessories & Consumables

End User

Research Institutes
Others
Pharmaceutical & Biotechnology Companies
Physician Offices
Clinical Laboratories
Hospitals

Disease

Eye Infections
Hepatitis
Tropical Fever
Immunosuppression
Other Diseases
Childhood Infections
Meningitis
Sexually Transmitted Infections
Gastroenteritis
Respiratory Infections

Infection Type

Others
Parasites
Fungal
Bacterial
Viral

Distribution Channel

Others
Retail Sales
Direct Tender

Europe Syndromic Multiplex Diagnostic Market Data Coverage Insights

Study Period	2024-2032
Base Year	2024
Unit	Revenue in USD Billion
Market Value in 2024	1.17 USD Billion
Market Value in 2032	2.20 USD Billion
CAGR (2025-2032)	8.22%
Historic Data	2016-2023
Market Segments Covered	Product Type,End User,Disease,Infection Type,Distribution Channel

Regional Insights:

Leading Market (2024-2032): Europe, leading in terms of revenue 1.17 USD Billion in 2024
- Key Country: Germany, leading in terms of revenue with value of 274.71 USD Million in 2024.

Segments and Scope

Europe Syndromic Multiplex Diagnostic Market to 2032, By Product Type
- Accessories & Consumables is the largest segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 732.85 USD Billion in the year 2024.
- Accessories & Consumables is the Fastest growing segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 8.52 % in forecast period 2025-2032.
Europe Syndromic Multiplex Diagnostic Market to 2032, By End User
- Hospitals is the largest segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 525.51 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 8.64 % in forecast period 2025-2032.
Europe Syndromic Multiplex Diagnostic Market to 2032, By Disease
- Respiratory Infections is the largest segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 392.84 USD Billion in the year 2024.
- Respiratory Infections is the Fastest growing segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 9.40 % in forecast period 2025-2032.
Europe Syndromic Multiplex Diagnostic Market to 2032, By Infection Type
- Viral is the largest segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 546.46 USD Billion in the year 2024.
- Viral is the Fastest growing segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 8.50 % in forecast period 2025-2032.
Europe Syndromic Multiplex Diagnostic Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 823.15 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 8.36 % in forecast period 2025-2032.

Europe Syndromic Multiplex Diagnostic Market Company Share Analysis

Company Name
Thermo Fisher Scientific Inc.
QIAGEN
BIOMÉRIEUX
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd.

Europe Syndromic Multiplex Diagnostic Market Geographical Sales Distribution, 2018-2032 USD Billion

Europe Syndromic Multiplex Diagnostic Market Company Profiling

Industry Related Reports

Global Cleanroom Technology Market

Global Cochlear Implant Market

Global Chronic Diseases Management Market

Global Hospital Furniture Market

Global Human Fibrin Glue Market

Global Healthcare 3D Printing Market

Global Hydrocephalus Market

Global Intraoperative Radiation Therapy Market

Global Surgical Power Tools Market

Global Inorganic Scintillators Market

Frequently Asked Questions

What are the primary segments covered in the Europe Syndromic Multiplex Diagnostic Market?

The Europe Syndromic Multiplex Diagnostic Market is segmented based on Segmentation Product Type,End User,Disease,Infection Type,Distribution Channel.

What is the current market size of the Europe Syndromic Multiplex Diagnostic Market?

Europe Syndromic Multiplex Diagnostic Market was valued at USD 1.17(Revenue in USD Billion) in 2024.

What is the expected growth rate of the Europe Syndromic Multiplex Diagnostic Market?

Europe Syndromic Multiplex Diagnostic Market is projected to grow at a CAGR of 8.22% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Europe Syndromic Multiplex Diagnostic Market?

The Direct Tender segment is expected to dominate the Europe Syndromic Multiplex Diagnostic Market, holding a largest market share of 0.82 USD Billion in 2024